(+/-)-VestitolCAS# 56701-24-7 |
- Vestitol
Catalog No.:BCN5309
CAS No.:35878-41-2
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 56701-24-7 | SDF | Download SDF |
PubChem ID | 92503 | Appearance | Powder |
Formula | C16H16O4 | M.Wt | 272.29 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3-(2-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-chromen-7-ol | ||
SMILES | COC1=CC(=C(C=C1)C2CC3=C(C=C(C=C3)O)OC2)O | ||
Standard InChIKey | XRVFNNUXNVWYTI-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C16H16O4/c1-19-13-4-5-14(15(18)8-13)11-6-10-2-3-12(17)7-16(10)20-9-11/h2-5,7-8,11,17-18H,6,9H2,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Vestitol has antioxidation, anti-inflammatory and antimicrobial activities, it can strongly act in a low dose and concentration and have a promising potential to be applied in the pharmaceutical and food industries. Vestitol inhibits neutrophils migration in the inflammatory process. |
Targets | CXCR | NOS | Antifection | Immunology & Inflammation related |
In vitro | Anti-inflammatory and antimicrobial evaluation of neovestitol and vestitol isolated from Brazilian red propolis.[Pubmed: 23607483 ]J Agric Food Chem. 2013 May 15;61(19):4546-50.The objective of this study was to evaluate anti-inflammatory and antimicrobial activities of neovestitol and vestitol((+/-)-Vestitol) isolated from Brazilian red propolis (BRP).
Antioxidation Activities of Natural Components from Dalbergia odorifera T.Chen[Reference: WebLink]Fine Chemicals, 2004, 21(7):525-8.The antioxidation activities of natural components extracted from Dalbergia odorifera T.Chen on lard and ascidian oil were investigated by OSI.
|
In vivo | Vestitol Isolated from Brazilian Red Propolis Inhibits Neutrophils Migration in the Inflammatory Process: Elucidation of the Mechanism of Action.[Pubmed: 26938776 ]J Nat Prod. 2016 Apr 22;79(4):954-60.Vestitol((+/-)-Vestitol) is an isoflavonoid isolated from Brazilian red propolis with potential anti-inflammatory activity. This study investigated the mechanism of action of vestitol on the modulation of neutrophil migration in the inflammatory process. |
(+/-)-Vestitol Dilution Calculator
(+/-)-Vestitol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.6726 mL | 18.3628 mL | 36.7255 mL | 73.4511 mL | 91.8139 mL |
5 mM | 0.7345 mL | 3.6726 mL | 7.3451 mL | 14.6902 mL | 18.3628 mL |
10 mM | 0.3673 mL | 1.8363 mL | 3.6726 mL | 7.3451 mL | 9.1814 mL |
50 mM | 0.0735 mL | 0.3673 mL | 0.7345 mL | 1.469 mL | 1.8363 mL |
100 mM | 0.0367 mL | 0.1836 mL | 0.3673 mL | 0.7345 mL | 0.9181 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Orteronel
Catalog No.:BCC1823
CAS No.:566939-85-3
- 2-Benzylacrylic acid
Catalog No.:BCC8564
CAS No.:5669-19-2
- Batatasin III
Catalog No.:BCN3596
CAS No.:56684-87-8
- Z-Arg-OH.HCl
Catalog No.:BCC3061
CAS No.:56672-63-0
- D-Phenylglycinol
Catalog No.:BCC2712
CAS No.:56613-80-0
- H-D-Phe(4-NO2)-OH
Catalog No.:BCC3274
CAS No.:56613-61-7
- BOP reagent
Catalog No.:BCC2807
CAS No.:56602-33-6
- Formestane
Catalog No.:BCC4369
CAS No.:566-48-3
- 7Beta-Hydroxycholesterol
Catalog No.:BCN2751
CAS No.:566-27-8
- 7-Keto-dehydroepiandrosterone
Catalog No.:BCC8780
CAS No.:566-19-8
- 3-Hydroxy-2-phenyl-propanamide
Catalog No.:BCN3905
CAS No.:56598-62-0
- PIT
Catalog No.:BCC7151
CAS No.:56583-49-4
- Z-Glu-OMe
Catalog No.:BCC2779
CAS No.:5672-83-3
- Icariside I
Catalog No.:BCN3463
CAS No.:56725-99-6
- 1-Methoxyallocryptopine
Catalog No.:BCN7454
CAS No.:56743-52-3
- Phenylalanine betaine
Catalog No.:BCN5761
CAS No.:56755-22-7
- Etifoxine hydrochloride
Catalog No.:BCC1561
CAS No.:56776-32-0
- Scopoletin acetate
Catalog No.:BCN5762
CAS No.:56795-51-8
- Lycoramine
Catalog No.:BCN2866
CAS No.:21133-52-8
- Melicopine
Catalog No.:BCC8210
CAS No.:568-01-4
- Tanshinone IIA
Catalog No.:BCN5763
CAS No.:568-72-9
- Tanshinone I
Catalog No.:BCN5764
CAS No.:568-73-0
- H-Gly-OMe.HCl
Catalog No.:BCC2951
CAS No.:5680-79-5
- H-Ser-OMe.HCl
Catalog No.:BCC3029
CAS No.:5680-80-8
Anti-inflammatory and antimicrobial evaluation of neovestitol and vestitol isolated from Brazilian red propolis.[Pubmed:23607483]
J Agric Food Chem. 2013 May 15;61(19):4546-50.
The objective of this study was to evaluate anti-inflammatory and antimicrobial activities of neovestitol and vestitol isolated from Brazilian red propolis (BRP). BRP ethanolic extract (EEP), neovestitol, and vestitol were evaluated by anti-inflammatory properties using a neutrophil migration assay. The antimicrobial activity was evaluated by minimal inhibitory and bactericidal concentrations (MIC and MBC) against Streptococcus mutans , Streptococcus sobrinus , Staphylococcus aureus , and Actinomyces naeslundii . Neovestitol, vestitol, and EEP inhibited neutrophil migration at a dose of 10 mg/kg. Regarding antimicrobial activity, neovestitol showed MICs ranging from <6.25 to 25-50 mug/mL and MBCs ranging from 25-50 to 50-100 mug/mL, while vestitol showed MICs ranging from 25-50 to 50-100 mug/mL and MBCs ranging from 25-50 to 50-100 mug/mL. Both isoflavonoids neovestitol and vestitol are consistent bioactive compounds displaying anti-inflammatory and antimicrobial activities that can strongly act in a low dose and concentration and have a promising potential to be applied in the pharmaceutical and food industries.
Vestitol Isolated from Brazilian Red Propolis Inhibits Neutrophils Migration in the Inflammatory Process: Elucidation of the Mechanism of Action.[Pubmed:26938776]
J Nat Prod. 2016 Apr 22;79(4):954-60.
Vestitol is an isoflavonoid isolated from Brazilian red propolis with potential anti-inflammatory activity. This study investigated the mechanism of action of vestitol on the modulation of neutrophil migration in the inflammatory process. Pre-treatment with vestitol at 1, 3, or 10 mg/kg reduced LPS- or mBSA-induced neutrophil migration and the release of CXCL1/KC and CXCL2/MIP-2 in vivo. Likewise, pre-treatment with vestitol at 1, 3, or 10 muM reduced the levels of CXCL1/KC and CXCL2/MIP-2 in macrophage supernatants in vitro. Moreover, the administration of vestitol (10 mg/kg) reduced leukocyte rolling and adherence in the mesenteric microcirculation of mice. The pre-treatment with vestitol (10 mg/kg) in iNOS(-/-) mice did not block its activity concerning neutrophil migration. With regard to the activity of vestitol on neutrophils isolated from the bone marrow of mice, there was a reduction on the chemotaxis of CXCL2/MIP-2 or LTB4-induced neutrophils and on calcium influx after pre-treatment with the compound at 3 or 10 muM. There was no change in CXCR2 expression by neutrophils treated with vestitol at 10 muM. These findings demonstrate that vestitol is a promising novel anti-inflammatory agent.